OncoTICE® powder for instillation fluid for intravesical use containing 2-8 x 108 CFU Tice BCG.

A Study of Intravesical Bacillus Calmette-Guerin (BCG) in Combination With ALT-803 (N-803) in Patients With Non-Muscle Invasive Bladder Cancer

A Phase III Randomized, Open-Label, Multi-Center, GlobalStudy of Durvalumab and Bacillus Calmette-Guerin (BCG)Administered as Combination Therapy Versus BCG Alone inHigh-Risk, BCG Naïve Non Muscle Invasive Bladder Cancer Patients (POTOMAC)